https://www.onhealthcare.tech/p/cms-ends-the-part-d-premium-stabilizationThoughts on Healthcare Markets & Technologyen2026-08-03T11:46:48+00:00CMS Ends the Part D Premium Stabilization Demo After CY 2026, Sets a 296.05 Dollar NAMBA and a 41.33 Dollar Base Premium, and Leaves a Standalone PDP Market That Shrank From 709 Plans to 360https://www.onhealthcare.tech/p/part-ii-cms-ends-the-part-d-premiumThoughts on Healthcare Markets & Technologyen2026-08-03T11:41:42+00:00Part II: CMS Ends the Part D Premium Stabilization Demo After CY 2026, Sets a 296.05 Dollar NAMBA and a 41.33 Dollar Base Premium, and Leaves a Standalone PDP Market That Shrank From 709 Plans to 360https://www.onhealthcare.tech/p/part-i-cms-ends-the-part-d-premiumThoughts on Healthcare Markets & Technologyen2026-08-03T11:40:11+00:00Part I: CMS Ends the Part D Premium Stabilization Demo After CY 2026, Sets a 296.05 Dollar NAMBA and a 41.33 Dollar Base Premium, and Leaves a Standalone PDP Market That Shrank From 709 Plans to 360https://www.onhealthcare.tech/p/unpacking-the-fy-2027-ipps-final-5baThoughts on Healthcare Markets & Technologyen2026-08-02T14:53:21+00:00Unpacking the FY 2027 IPPS Final Rule CMS-1849-F: How Mandatory Electronic Prior Auth, FHIR APIs, Sepsis Readmission Penalties, and Expanded eCQMs Are Reshaping Hospital Tech Investment Prioritieshttps://www.onhealthcare.tech/p/unpacking-the-fy-2027-ipps-finalThoughts on Healthcare Markets & Technologyen2026-08-02T14:28:56+00:00Unpacking the FY 2027 IPPS Final Rule CMS-1849-F: How Mandatory Electronic Prior Auth, FHIR APIs, Sepsis Readmission Penalties, and Expanded eCQMs Are Reshaping Hospital Tech Investment Priorities